Cosmetic Contact® Sales Expansion
First written in FY2016-Q3. 10 of 33 entries say "Advanced", first in FY2016. Latest entry: FY2025-H1.
0 other companies' latest entry also says "Other".
- FY2025-H1Substantial revenue decline following the withdrawal from e-commerce by a Chinese subsidiaryAnnual report
「Net sales for the current interim consolidated accounting period fell sharply to ¥1,072.704 million, down 24.1% year on year, due to the withdrawal of the Chinese second-tier subsidiary from the contact lens e-commerce business.」
The withdrawal from the Chinese contact lens e-commerce business was reflected in actual results as a 24.1% year-on-year decline in contact lens-related sales. - FY2024Slight decline in related sales due to the transfer of the China businessAnnual report
「In Japan, highly profitable colored lenses performed strongly, but overall sales edged down 1.1% year on year to ¥2,508.390 million due in part to the sale of a consolidated subsidiary (second-tier subsidiary) engaged in the contact lens business in China.」
While highly profitable colored lenses performed strongly in Japan, related sales fell 1.1% for the full year due to the impact of the sale of a second-tier subsidiary engaged in the contact lens business in China. - FY2024-Q2AdvancedAnnual report
「Net sales for the first six months of the current consolidated fiscal year amounted to ¥1,413.014 million, up 11.5% year on year, as highly profitable colored lenses performed strongly.」
Contact lens-related sales increased 11.5% year on year on strong performance by highly profitable colored lenses, and sales expansion continued. - FY2024-Q1AdvancedAnnual report
「Net sales for the first three months of the current consolidated fiscal year amounted to ¥717.069 million, up 13.9% year on year, as highly profitable colored lenses performed strongly.」
Contact lens-related sales increased 13.9% year on year as highly profitable colored lenses performed strongly, indicating progress in sales expansion. - FY2023AdvancedAnnual report
「Overall sales edged up 0.6% year on year to ¥2,535.670 million for the current consolidated fiscal year, despite variation by business format and region.」
Contact lens-related sales increased 0.6% year on year in FY2023, turning to a slight full-year increase from the decline in FY2023-Q3. - FY2023-Q3Revenue decline due to the impact of China and other markets despite domestic sales growthAnnual report
「Net sales for the first nine months of the current consolidated fiscal year amounted to ¥1,811.132 million, down 2.8% year on year. The Company secured higher sales in the domestic market, but sales declined due to the impact of lockdowns in China and intensifying competition with local manufacturers.」
While the Company secured higher sales in the domestic market, contact lens-related sales fell 2.8% year on year due to lockdowns in China and intensifying competition with local manufacturers. - FY2023-Q2AdvancedAnnual report
「Net sales for the first six months of the current consolidated fiscal year amounted to ¥1,267.400 million, up 3.5% year on year. The Company secured substantial sales growth in the domestic market despite the impact of lockdowns in overseas markets, particularly China.」
While the impact of lockdowns in China persisted, the Company secured substantial sales growth in the domestic market, and contact lens-related sales increased 3.5% year on year. - FY2023-Q1AdvancedAnnual report
「Net sales for the first three months of the current consolidated fiscal year amounted to ¥629.493 million, up 6.0% year on year. The Company secured substantial sales growth in the domestic market despite the impact of lockdowns in overseas markets, particularly China.」
While the impact of lockdowns in China persisted, contact lens-related sales increased 6.0% year on year on substantial domestic sales growth, turning to an increase from the previous fiscal year's full-year decline. - FY2022Recovery in domestic demand offset by declining sales in ChinaAnnual report
「Demand for contact lenses in Japan recovered in both the B2B and B2C markets, while the Chinese market was affected by lockdowns and intensifying competition with Chinese companies, resulting in overall sales of ¥2,521.679 million, down 6.2% year on year.」
While domestic B2B and B2C demand recovered, contact lens-related sales fell 6.2% for the full year due to lockdowns in China and intensifying competition. - FY2022-Q3Domestic sales growth, but overseas demand has not recovered due to China's lockdownsAnnual report
「Net sales for the first nine months of the current consolidated fiscal year edged down 1.1% year on year to ¥1,864.046 million. The Company secured higher sales in the domestic market, as it did in cosmetics and cosmetic accessories, following the easing of restrictions on activities, but overseas demand did not recover due to the impact of lockdowns in China, the main market, among other factors.」
While sales in the domestic market increased following the easing of restrictions on activities, overseas demand did not recover due to lockdowns in China and other factors, and contact lens-related sales fell 1.1% year on year. - FY2022-Q1Revenue decline due to overseas weakness in colored-lens demand despite domestic sales growthAnnual report
「Net sales for the first three months of the current consolidated fiscal year amounted to ¥593.696 million, down 6.3% year on year. The Company secured higher sales in the domestic market, but demand for colored lenses in overseas markets did not recover.」
While sales increased in the domestic market, contact lens-related sales fell 6.3% year on year as demand for colored lenses in overseas markets did not recover. - FY2021Narrower full-year revenue decline amid continued overseas sales growthAnnual report
「Net sales for the current consolidated fiscal year amounted to ¥2,689.474 million, down 0.9% year on year. Contact lens sales overseas continued to trend upward, but demand for contact lenses remained weak in Japan as consumers continued to refrain from going out.」
While overseas sales continued to trend upward, full-year sales fell 0.9% due to weak domestic demand. The decline narrowed from 18.1% in the previous fiscal year. - FY2021-Q3Narrower revenue decline amid continued overseas sales growthAnnual report
「Net sales for the first nine months of the current consolidated fiscal year amounted to ¥1,884.540 million, down 10.0% year on year. Contact lens sales overseas continued to trend upward, but demand for contact lenses remained weak in Japan as consumers continued to refrain from going out.」
While contact lens sales overseas continued to grow, related sales fell 10.0% year on year due to weak domestic demand. The decline narrowed from 13.2% in the previous quarter. - FY2021-Q2Revenue decline due to weak domestic demand despite overseas sales growthAnnual report
「Net sales for the first six months of the current consolidated fiscal year amounted to ¥1,291.381 million, down 13.2% year on year. Contact lens sales overseas continued to trend upward, but demand for contact lenses remained weak in Japan as consumers continued to refrain from going out.」
While contact lens sales overseas continued to grow, related sales fell 13.2% year on year due to weak domestic demand. - FY2021-Q1Decline in contact lens-related sales amid the infectious diseaseAnnual report
「Net sales for the first three months of the current consolidated fiscal year amounted to ¥633.571 million, down 17.9% year on year. Sales of clear lenses increased, but demand for daily disposable colored lenses remained weak as consumers continued to refrain from going out.」
The policy of expanding sales of contact lens-related products, including cosmetic contact lenses, continued, but related sales fell 17.9% year on year due to weak demand for daily disposable colored lenses as consumers refrained from going out. - FY2020Full-year revenue decline due to the infectious disease and selection and concentrationAnnual report
「Net sales for the current consolidated fiscal year amounted to ¥2,713.617 million, down 18.1% year on year. Sales in China and of clear lenses increased, but demand for daily disposable colored lenses remained weak as consumers refrained from going out, while the Company continued to select and concentrate its contact lens product brands and customers.」
While sales in China and of clear lenses increased, contact lens-related sales fell 18.1% for the full year due to weak demand for daily disposable colored lenses and the selection and concentration of brands and customers. - FY2020-Q3Wider revenue decline due to the infectious disease and selection and concentrationAnnual report
「Net sales for the first nine months of the current consolidated fiscal year amounted to ¥2,093.705 million, down 11.8% year on year. Sales in China and of clear lenses increased, but demand for daily disposable colored lenses remained weak as consumers refrained from going out, while the Company continued to select and concentrate its contact lens product brands and customers.」
While sales in China and of clear lenses increased, contact lens-related sales fell 11.8% year on year due to weak demand for daily disposable colored lenses and the selection and concentration of brands and customers. The decline widened from 8.9% in the previous quarter. - FY2020-Q2Narrower revenue decline while continuing selection and concentrationAnnual report
「Net sales for the first six months of the current consolidated fiscal year amounted to ¥1,487.885 million, down 8.9% year on year. Sales of prescription lenses were relatively steady, but the Company continued to select and concentrate its contact lens product brands and customers.」
The Company continued to select and concentrate its brands and customers. Related sales fell 8.9% year on year, but the decline narrowed from 12.0% in FY2020-Q1. - FY2020-Q1Narrower revenue decline while continuing selection and concentrationAnnual report
「Net sales for the first three months of the current consolidated fiscal year amounted to ¥771.627 million, down 12.0% year on year, mainly because the Company has continued to select and concentrate its contact lens product brands and customers.」
The Company continued to select and concentrate its brands and customers, and contact lens-related sales fell 12.0% year on year. The decline narrowed from 13.1% in the year-earlier period. - FY2019Full-year revenue decline, with the rate of decline narrowing, due to selection and concentrationAnnual report
「Net sales for the current consolidated fiscal year amounted to ¥3,313.680 million, down 14.1% year on year, mainly because the Company has been selecting and concentrating its contact lens product brands and customers.」
As the Company continued to select and concentrate its brands and customers, contact lens-related sales fell 14.1% for the full year. The decline narrowed from 18.0% in the first nine months. - FY2019-Q3Wider revenue decline due to selection and concentrationAnnual report
「Net sales for the first nine months of the current consolidated fiscal year amounted to ¥2,374.170 million, down 18.0% year on year, mainly because the Company has been selecting and concentrating its contact lens product brands and customers.」
While continuing to select and concentrate its brands and customers, the decline in contact lens-related sales widened from 13.1% in the first quarter and 16.6% in the second quarter to 18.0%. - FY2019-Q2Wider revenue decline due to brand and customer selection and concentrationAnnual report
「Net sales for the first six months of the current consolidated fiscal year amounted to ¥1,633.402 million, down 16.6% year on year, mainly because the Company has been selecting and concentrating its contact lens product brands and customers.」
While continuing to select and concentrate its contact lens product brands and customers, the decline in related sales widened from 13.1% in the first quarter to 16.6%. - FY2019-Q1Revenue decline due to the selection and concentration of brands and customersAnnual report
「Net sales for the first three months of the current consolidated fiscal year amounted to ¥876.826 million, down 13.1% year on year, mainly because the Company has been selecting and concentrating its contact lens product brands and customers.」
While continuing to pursue sales expansion centered on cosmetic contact lenses, related sales fell 13.1% year on year as the Company selected and concentrated its contact lens product brands and customers. - FY2018AdvancedAnnual report
「Revenue from contact lens-related products was ¥3,856.308 million, up 10.0% year on year, due to steady growth in sales of core brand products and strong sales of related products such as contact lens cases.」
Contact lens-related revenue, including Cosmetic Contact, increased 10.0% year on year, demonstrating full-year sales growth. - FY2018-Q3AdvancedAnnual report
「Revenue for the first nine months of the current consolidated cumulative period was ¥2,894.885 million, up 11.7% year on year, as sales of core brand products expanded steadily.」
Contact lens-related revenue increased 11.7% year on year as sales of core brand products expanded, demonstrating continued sales growth. - FY2018-Q2AdvancedAnnual report
「Revenue for the first half of the current consolidated cumulative period was ¥1,959.672 million, up 15.9% year on year, as sales of core brand products expanded steadily.」
Contact lens-related revenue increased 15.9% year on year as sales of core brand products expanded, demonstrating tangible progress in expanding sales, particularly of Cosmetic Contact. - FY2018-Q1AdvancedAnnual report
「We intend to continue pursuing overseas sales growth, particularly for Cosmetic Contact®. Revenue for the first quarter of the current consolidated cumulative period was ¥1,009.189 million, up 9.4% year on year, as sales of core brand products expanded steadily.」
The policy of expanding overseas sales, particularly of Cosmetic Contact, continued, while contact lens-related revenue increased 9.4% year on year due to growth in sales of core brand products. - FY2017Full-year revenue decline amid delays in regulatory approvals for new productsAnnual report
「Revenue for the consolidated fiscal year was ¥3,505.773 million, down 1.2% year on year, due to the reaction to the launch of major products in the previous fiscal year, delays in obtaining regulatory approvals for new products and other factors.」
Although the priority policy for Cosmetic Contact® continued, full-year contact lens-related revenue declined 1.2%, with delays in obtaining regulatory approvals for new products identified as a factor behind the decline. - FY2017-Q3Narrowing decline in salesAnnual report
「Revenue for the first nine months of the current consolidated cumulative period was ¥2,590.909 million, down 1.1% year on year, due to the reaction to the launch of a major product in the same period of the previous year.」
The policy of prioritizing Cosmetic Contact® continues. Although contact lens-related revenue declined, the rate of decline narrowed from 5.3% in the first half to 1.1%. - FY2017-Q2RestatedAnnual report
「Revenue for the first half of the current consolidated cumulative period was ¥1,691.167 million, down 5.3% year on year, due to the reaction to the launch of a major product in the same period of the previous year.」
While the priority policy for Cosmetic Contact® continued, contact lens-related revenue declined due to the reaction to the previous year's major product launch. - FY2017-Q1Revenue decline following the impact of the previous year's major product launchAnnual report
「Revenue for the first quarter of the current consolidated cumulative period was ¥922.132 million, down 7.9% year on year, due to the reaction to the launch of a major product in the same period of the previous year.」
While Cosmetic Contact® continued to be a priority initiative, contact lens-related revenue declined due to the reaction to the launch of a major product in the same period of the previous year. - FY2016AdvancedAnnual report
「Revenue from contact lens-related products increased by ¥334.009 million from the previous consolidated fiscal year, driven by the acquisition of new customers and higher sales to existing customers.」
The acquisition of new customers and higher sales to existing customers resulted in tangible revenue growth in contact lens-related products. - FY2016-Q3First statedAnnual report
「Our group actively pursued the expansion of sales of Cosmetic Contact®, a priority product (Note 1), and also worked to strengthen sales of OEM and custom-order products (Note 2) in response to growing demand for differentiation amid intensifying competition in the retail industry.」
Cosmetic Contact® has been positioned as a priority product, with the company aiming to expand sales.